# LetsGetChecked

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/letsgetchecked

- Industry: Healthcare
- Headquarters: Dublin, Ireland
- Website: www.letsgetchecked.com
- Total disclosed funding: $502M
- Latest round: Series F (Jan 8, 2025)
- Investors on record: 11

## About

LetsGetChecked, based in Ireland, specializes in at-home health testing and telehealth services, empowering individuals to manage their health conveniently and privately through innovative diagnostic solutions.Founded in 2013 in Dublin, Ireland, LetsGetChecked focuses on direct-to-consumer health testing solutions. The company was established by Peter Foley, who continues to lead as CEO. It has successfully raised USD 165 mn in Series F funding from Optum Ventures in January 2025, bringing its total amount raised to USD 165 mn across 8 deals.LetsGetChecked offers a comprehensive suite of at-home health testing kits and telehealth services. Their core products include diagnostic tests for conditions such as cancer, hormonal imbalances, infectious diseases, and general wellness, facilitated through their in-house manufacturing and CLIA-certified laboratory. The service model emphasizes direct-to-consumer engagement, allowing patients to order tests online, collect samples at home, and receive results securely. Customers consist of individual consumers and healthcare providers, primarily in the United States, focusing on accessible healthcare solutions.In 2023, LetsGetChecked reported a revenue of USD 7.90 mn and an EBITDA of USD -45.85 mn, generated primarily through the sale of health testing kits and telehealth consultations. The company's revenue model includes both one-time purchases and subscriptions for ongoing health monitoring, catering to users seeking continuous health insights.In January 2025, LetsGetChecked plans to utilize the newly raised USD 165 mn in Series F funding to expand its product offerings, enhance laboratory technologies, optimize logistics, and strengthen its medical support frameworks. The company aims to develop new products and improve efficiency in at-home healthcare services, with specific plans to enter new markets as part of its growth strategy.

## Funding rounds

- Series F, Jan 8, 2025, $165M — Optum Ventures
- Series E, Dec 1, 2022, $74M — Transformation Capital, Optum Ventures, Elkstone Ventures, Symphony Ventures
- Series D, Jun 7, 2021, $150M — CF Private Equity, HLM Venture Partners, Qiming Venture Partners, Casdin Capital, Transformation Capital, Illumina Ventures, Optum Ventures
- Series C, May 5, 2020, $71M — CF Private Equity, HLM Venture Partners, Deerfield Management, Transformation Capital, Illumina Ventures, Optum Ventures, Angeles Investments
- Series B, May 8, 2019, $30M — Qiming Venture Partners, Transformation Capital, Optum Ventures
- Series A, Mar 28, 2018, $12M — Qiming Venture Partners, Optum Ventures

## Investors

- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B, Series D
- Optum Ventures (https://capitalatlas.ai/funds/optum-ventures) — Series A, Series B, Series C, Series D, Series E, Series F
- Transformation Capital (https://capitalatlas.ai/funds/transformation-capital) — Series B, Series C, Series D, Series E
- CF Private Equity (https://capitalatlas.ai/funds/cf-private-equity) — Series C, Series D
- HLM Venture Partners (https://capitalatlas.ai/funds/hlm-venture-partners) — Series C, Series D
- Deerfield Management (https://capitalatlas.ai/funds/deerfield-management) — Series C
- Illumina Ventures (https://capitalatlas.ai/funds/illumina-ventures) — Series C, Series D
- Angeles Investments — Series C
- Casdin Capital (https://capitalatlas.ai/funds/casdin-capital) — Series D
- Elkstone Ventures (https://capitalatlas.ai/funds/elkstone-ventures) — Series E
- Symphony Ventures (https://capitalatlas.ai/funds/symphony-ventures) — Series E